NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Allergies



OMNARIS(TM) Nasal Spray Now Available by Prescription for Patients with Seasonal and Perennial Allergies



May 2nd, 2008

Sepracor Inc. (Nasdaq: SEPR) announced that OMNARIS(TM) (ciclesonide) Nasal Spray is now available by prescription in pharmacies nationwide. OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older, and with perennial allergic rhinitis in adults and adolescents 12 years of age and older.

"We believe that OMNARIS Nasal Spray is a strategically seamless fit with our proprietary portfolio of respiratory products," said Adrian Adams, President and Chief Executive Officer of Sepracor. "Our commercial organization has had significant experience in promoting respiratory...


Source: Health Business Week (2008-05-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login